KETAMINE

Ketamine Adverse Events Reported to the FDA Over Time

How are Ketamine adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Ketamine, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Ketamine is flagged as the suspect drug causing the adverse event.

Most Common Ketamine Adverse Events Reported to the FDA

What are the most common Ketamine adverse events reported to the FDA?

Drug Abuse	82 (2.1%)
Haematuria	71 (1.82%)
Renal Failure Acute	62 (1.59%)
Dilatation Intrahepatic Duct Acquir...	61 (1.56%)
Hepatotoxicity	60 (1.53%)
Drug Ineffective	54 (1.38%)
Liver Function Test Abnormal	51 (1.3%)
Cystitis	47 (1.2%)
Hypotension	47 (1.2%)
Hydronephrosis	46 (1.18%)
Anaphylactic Shock	40 (1.02%)
	Show More
Drug Interaction	40 (1.02%)
Venoocclusive Liver Disease	40 (1.02%)
Alanine Aminotransferase Increased	39 (1%)
Oliguria	38 (.97%)
Blood Alkaline Phosphatase Increase...	37 (.95%)
Bradycardia	36 (.92%)
Cardiac Arrest	32 (.82%)
Bladder Disorder	30 (.77%)
Lymphopenia	29 (.74%)
Stevens-johnson Syndrome	28 (.72%)
Acute Hepatic Failure	27 (.69%)
Pollakiuria	27 (.69%)
Completed Suicide	25 (.64%)
Cystitis Ulcerative	25 (.64%)
Multiple Drug Overdose	24 (.61%)
Aspergillosis	22 (.56%)
Circulatory Collapse	22 (.56%)
Contracted Bladder	22 (.56%)
Oxygen Saturation Decreased	22 (.56%)
Blood Creatinine Increased	21 (.54%)
Drug Toxicity	21 (.54%)
Bronchospasm	20 (.51%)
Confusional State	20 (.51%)
Drug Abuser	20 (.51%)
Pain	20 (.51%)
Blood Bilirubin Increased	19 (.49%)
Loss Of Consciousness	19 (.49%)
Nausea	19 (.49%)
Venoocclusive Disease	19 (.49%)
Apnoea	18 (.46%)
Drug Screen Positive	18 (.46%)
Dysuria	18 (.46%)
Micturition Urgency	18 (.46%)
Off Label Use	18 (.46%)
Pleural Effusion	18 (.46%)
Tachycardia	18 (.46%)
Toxic Epidermal Necrolysis	18 (.46%)
Accidental Death	17 (.43%)
Agitation	17 (.43%)
Cholestasis	17 (.43%)
Convulsion	17 (.43%)
Death	17 (.43%)
Medication Error	17 (.43%)
Product Quality Issue	17 (.43%)
Somnolence	17 (.43%)
Acute Pulmonary Oedema	16 (.41%)
Urge Incontinence	16 (.41%)
Depressed Level Of Consciousness	15 (.38%)
Generalised Erythema	15 (.38%)
Heart Rate Increased	15 (.38%)
Overdose	15 (.38%)
Rash	15 (.38%)
Septic Embolus	15 (.38%)
Vomiting	15 (.38%)
Brain Death	14 (.36%)
Brain Stem Syndrome	14 (.36%)
Delirium	14 (.36%)
Gamma-glutamyltransferase Increased	14 (.36%)
Hallucination	14 (.36%)
Hepatic Necrosis	14 (.36%)
Respiratory Failure	14 (.36%)
Constipation	13 (.33%)
Erythema	13 (.33%)
Respiratory Depression	13 (.33%)
Sedation	13 (.33%)
Septic Shock	13 (.33%)
Suicide Attempt	13 (.33%)
Cystitis Interstitial	12 (.31%)
Drug Rash With Eosinophilia And Sys...	12 (.31%)
Intentional Drug Misuse	12 (.31%)
Pyrexia	12 (.31%)
Sepsis	12 (.31%)
Toxic Skin Eruption	12 (.31%)
Anuria	11 (.28%)
Anxiety	11 (.28%)
Biopsy Bladder Abnormal	11 (.28%)
Face Oedema	11 (.28%)
Fall	11 (.28%)
Hypothyroidism	11 (.28%)
Pyuria	11 (.28%)
Rhabdomyolysis	11 (.28%)
Urinary Tract Disorder	11 (.28%)
Biliary Dilatation	10 (.26%)
Blood Pressure Increased	10 (.26%)
Cardiac Failure	10 (.26%)
Cardio-respiratory Arrest	10 (.26%)
Condition Aggravated	10 (.26%)
Dizziness	10 (.26%)
Hyponatraemia	10 (.26%)
Malaise	10 (.26%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Ketamine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ketamine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Ketamine

What are the most common Ketamine adverse events reported to the FDA?

Hepatic And Hepatobiliary	204 (5.22%)
Neurological	199 (5.09%)
Renal Disorders	182 (4.66%)
Urinary Tract Signs	177 (4.53%)
Cardiac Arrhythmias	151 (3.86%)
Epidermal And Dermal Conditions	148 (3.79%)
Hepatobiliary	144 (3.68%)
Bladder And Bladder Neck Disorders	120 (3.07%)
Therapeutic And Nontherapeutic Effe...	120 (3.07%)
Respiratory	115 (2.94%)
Infections - Pathogen Unspecified	113 (2.89%)
	Show More
Psychiatric	113 (2.89%)
Medication Errors	99 (2.53%)
Bile Duct	83 (2.12%)
Decreased And Nonspecific Blood Pre...	78 (2%)
Allergic Conditions	66 (1.69%)
Cardiac And Vascular Investigations	56 (1.43%)
Procedural And Device Related Injur...	53 (1.36%)
Fatal Outcomes	52 (1.33%)
Gastrointestinal Signs	48 (1.23%)
Metabolic, Nutritional And Blood Ga...	47 (1.2%)
Suicidal And Self-injurious Behavio...	46 (1.18%)
Enzyme	43 (1.1%)
Renal And Urinary Tract Investigati...	42 (1.07%)
Lower Respiratory Tract Disorders	41 (1.05%)
Deliria	40 (1.02%)
White Blood Cell	39 (1%)
Anxiety Disorders	38 (.97%)
Seizures	37 (.95%)
Lifestyle Issues	35 (.9%)
Disturbances In Thinking	34 (.87%)
Vascular	34 (.87%)
Chemical Injury And Poisoning	32 (.82%)
Injuries	32 (.82%)
Muscle	32 (.82%)
Movement Disorders	29 (.74%)
Therapeutic Procedures And Supporti...	25 (.64%)
Body Temperature Conditions	24 (.61%)
Fungal Infectious	24 (.61%)
Viral Infectious	24 (.61%)
Bronchial Disorders	23 (.59%)
Toxicology And Therapeutic Drug Mon...	22 (.56%)
Upper Respiratory Tract Disorders	22 (.56%)
Thyroid Gland	20 (.51%)
Gastrointestinal Motility And Defec...	19 (.49%)
Hematology Investigations	19 (.49%)
Electrolyte And Fluid Balance Condi...	18 (.46%)
Pleural	18 (.46%)
Product Quality Issues	18 (.46%)
Heart Failures	16 (.41%)
Physical Examination Topics	16 (.41%)
Sleep Disorders	16 (.41%)
Bacterial Infectious	14 (.36%)
Administration Site Reactions	13 (.33%)
Mental Impairment	13 (.33%)
Immunology And Allergy	12 (.31%)
Metastases	12 (.31%)
Eye	11 (.28%)
Genitourinary Tract	11 (.28%)
Miscellaneous And Site Unspecified ...	11 (.28%)
Mood Disorders	11 (.28%)
Oral Soft Tissue Conditions	11 (.28%)
Ureteric	11 (.28%)
Coronary Artery	10 (.26%)
Depressed Mood Disorders	10 (.26%)
Hematological And Lymphoid Tissue T...	10 (.26%)
Neuromuscular	10 (.26%)
Acid-base	9 (.23%)
Exocrine Pancreas Conditions	9 (.23%)
Somatoform And Factitious	9 (.23%)
Tissue	9 (.23%)
Vision	9 (.23%)
Angiedema And Urticaria	8 (.2%)
Embolism And Thrombosis	8 (.2%)
Encephalopathies	8 (.2%)
Headaches	8 (.2%)
Immune	8 (.2%)
Musculoskeletal And Connective Tiss...	8 (.2%)
Pulmonary Vascular	8 (.2%)
Vascular Hemorrhagic	8 (.2%)
Vascular Hypertensive	8 (.2%)
Dissociative	7 (.18%)
Gallbladder	7 (.18%)
Ocular Infections, Irritations And ...	7 (.18%)
Ocular Neuromuscular	7 (.18%)
Schizophrenia And Other Psychotic	7 (.18%)
Spleen, Lymphatic And Reticulendoth...	7 (.18%)
Water, Electrolyte And Mineral	7 (.18%)
Adrenal Gland	6 (.15%)
Arteriosclerosis, Stenosis, Vascula...	6 (.15%)
Gastrointestinal Hemorrhages	6 (.15%)
Hypothalamus And Pituitary Gland	6 (.15%)
Inner Ear And Viiith Cranial Nerve	6 (.15%)
Manic And Bipolar Mood Disorders	6 (.15%)
Personality Disorders	6 (.15%)
Psychiatric And Behavioural Symptom...	6 (.15%)
Cardiac Disorder Signs	5 (.13%)
Central Nervous System Vascular	5 (.13%)
Communication Disorders	5 (.13%)
Glucose Metabolism Disorders	5 (.13%)
Hearing	5 (.13%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Ketamine, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Ketamine is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.